Detalhe da pesquisa
1.
Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer: everyday clinical practice in a single centre.
Anticancer Drugs
; 28(6): 654-659, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28252532
2.
Modified 3-week schedule of gemcitabine plus cisplatin for non-small cell lung cancer treatment.
J BUON
; 22(6): 1395-1403, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29332329
3.
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Lancet Oncol
; 17(8): 1137-1146, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402147
4.
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 15(4): 396-405, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24582486
5.
Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer.
Int J Gynecol Cancer
; 20(6): 953-7, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20683401
6.
Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.
J Clin Oncol
; 35(29): 3347-3353, 2017 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28825853
7.
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.
Int J Oncol
; 20(2): 419-27, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11788911
8.
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression.
Free Radic Res
; 37(2): 213-23, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12653210
9.
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy.
Oncol Rep
; 9(4): 887-96, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12066227
10.
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Oncol Rep
; 10(1): 197-206, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12469169
11.
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes.
Oncol Rep
; 10(3): 759-66, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12684655
12.
Reactive oxygen species, antioxidant mechanisms, and serum cytokine levels in cancer patients: impact of an antioxidant treatment.
J Environ Pathol Toxicol Oncol
; 22(1): 17-28, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12678402
13.
An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment.
Expert Opin Drug Metab Toxicol
; 9(8): 1037-51, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23705788
14.
Multiple rechallenges for castration-resistant prostate cancer patients responding to first-line docetaxel: assessment of clinical outcomes and predictive factors.
Urology
; 79(3): 644-9, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22386418
15.
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer.
Lung Cancer
; 68(2): 264-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19632738
16.
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer.
Cancer Chemother Pharmacol
; 65(6): 1197-202, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20140616
17.
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status.
Int J Cancer
; 98(1): 84-91, 2002 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11857390